Circulatory microRNA-142 as potential biomarker of disease progression in paediatric cystic fibrosis-associated liver disease

被引：0
|
作者：
Calvopina, D. A. [1 ]
Coleman, M. A. [1 ]
Fernandez-Rojo, M. A. [1 ]
Wockner, L. F. [2 ]
McDonald, C. J. [3 ]
Lewindon, P. J. [4 ]
Ramm, G. A. [1 ]
机构：
[1] QIMR Berghofer MRI, Hepat Fibrosis Grp, Brisbane, Qld, Australia
[2] QIMR Berghofer MRI, QIMR Berghofer Stat Unit, Brisbane, Qld, Australia
[3] QIMR Berghofer MRI, Membrane Transport Grp, Brisbane, Qld, Australia
[4] Lady Cilento Childrens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30457-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LBP-512
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [31] A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease
    Karnsakul, Wikrom
    Wasuwanich, Paul
    Ingviya, Thammasin
    Vasilescu, Alexandra
    Carson, Kathryn A.
    Mogayzel, Peter J.
    Schwarz, Kathleen B.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (04) : 546 - 552
  • [32] The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study
    Poetter-Lang, Sarah
    Staufer, Katharina
    Baltzer, Pascal
    Tamandl, Dietmar
    Muin, Dina
    Bastati, Nina
    Halilbasic, Emina
    Hodge, Jacqueline C.
    Trauner, Michael
    Kazemi-Shirazi, Lili
    Ba-Ssalamah, Ahmed
    EUROPEAN RADIOLOGY, 2019, 29 (02) : 1048 - 1058
  • [33] Cystic fibrosis associated liver disease in children
    Joseph J Valamparampil
    Girish L Gupte
    World Journal of Hepatology, 2021, (11) : 1727 - 1742
  • [34] Cystic fibrosis associated liver disease in children
    Valamparampil, Joseph J.
    Gupte, Girish L.
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (11) : 1727 - 1742
  • [35] Hydrolysable tannins as a potential therapeutic drug for the human fibrosis-associated disease
    Wang, Meiwei
    Cao, Linghui
    DRUG DEVELOPMENT RESEARCH, 2023, 84 (06) : 1096 - 1113
  • [36] Lower airway microbiota for "biomarker' measurements of cystic fibrosis disease progression?
    Sherrard, Laura J.
    Bell, Scott C.
    THORAX, 2018, 73 (11) : 1001 - 1003
  • [37] Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?
    Potter, CJ
    Fishbein, M
    Hammond, S
    McCoy, K
    Qualman, S
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997, 25 (01): : 32 - 36
  • [38] Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease
    Liu, Jinghua
    Walker, Nancy M.
    Ootani, Akifumi
    Strubberg, Ashlee M.
    Clarke, Lane L.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (03): : 1056 - 1068
  • [39] Surveillance for cystic fibrosis-associated hepatobiliary disease: Early ultrasound changes and predisposing factors
    Lenaerts, C
    Lapierre, C
    Patriquin, H
    Bureau, N
    Lepage, G
    Harel, F
    Marcotte, J
    Roy, CC
    JOURNAL OF PEDIATRICS, 2003, 143 (03): : 343 - 350
  • [40] The effect of genetic modifiers on phenotypic variation in cystic fibrosis-associated pulmonary disease.
    Hilmer, SC
    Merlo, CA
    Enke, RA
    Couch, ME
    Hoffman, EP
    Garcia, JGN
    Boyle, MP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 535 - 535
12345